Clinical Trials
- Other Cancers
test
- Ages18 years and older
- GenderBoth
- Brain, Spinal Cord & Nervous System
Myasthenia Gravis Inebilizumab Trial (MINT)
- Ages18 years and older
- GenderBoth
- Immune System
Pathogenic Wnt-beta catenin target genes in macrophages and fibrosis
- Leukemia
Phase II Study of Adding the Anti-PD-1 Pembrolizumab to Tyrosine Kinase Inhibitors in Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease
- Phase 1 Cancers
test